A call for clarity when discussing hydrogen peroxide vapour and aerosol systems

Journal of Hospital Infection

Volumn 77, Issue 1, 2011, Pages 83-84

  Otter, J A ^a   Yezli, S ^a  

^a Bioquell UK Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; STERUSIL; UNCLASSIFIED DRUG; VAPROX;

AERATION; AEROSOL; BACTERICIDAL ACTIVITY; BACTERIUM CONTAMINATION; BIOQUELL CONDENSING HYDROGEN PEROXIDE VAPOUR; BIOSAFETY; BIOTECHNOLOGY; CLOSTRIDIUM DIFFICILE; DEVICE; DRUG DELIVERY SYSTEM; INTERMETHOD COMPARISON; LETTER; MYCOBACTERIUM TUBERCULOSIS; NATIONAL HEALTH SERVICE; NONHUMAN; RISK REDUCTION; SPORE GERMINATION; STERINIS SYSTEM; STERIS NON CONDENSING VAPORISED HYDROGEN PEROXIDE; VAPOR;

AEROSOLS; AIR MICROBIOLOGY; DISINFECTANTS; DISINFECTION; HYDROGEN PEROXIDE; MYCOBACTERIUM TUBERCULOSIS;

EID: 78650512722     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2010.07.023     Document Type: Letter

References (10)

1. Andersen B.M., Syversen G., Thoresen H., et al. Failure of dry mist of hydrogen peroxide 5% to kill Mycobacterium tuberculosis. J Hosp Infect 2010, 76:80-83.
2. Kahnert A., Seiler P., Stein M., Aze B., McDonnell G., Kaufmann S.H. Decontamination with vaporized hydrogen peroxide is effective against Mycobacterium tuberculosis. Lett Appl Microbiol 2005, 40:448-452.
3. Grare M., Dailloux M., Simon L., Dimajo P., Laurain C. Efficacy of dry mist of hydrogen peroxide (DMHP) against Mycobacterium tuberculosis and use of DMHP for routine decontamination of biosafety level 3 laboratories. J Clin Microbiol 2008, 46:2955-2958.
4. Hall L., Otter J.A., Chewins J., Wengenack N.L. Use of hydrogen peroxide vapor for deactivation of Mycobacterium tuberculosis in a biological safety cabinet and a room. J Clin Microbiol 2007, 45:810-815.
5. Boyce J.M. New approaches to decontamination of rooms after patients are discharged. Infect Control Hosp Epidemiol 2009, 30:515-517.
6. Barbut F., Menuet D., Verachten M., Girou E. Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores. Infect Control Hosp Epidemiol 2009, 30:515-517.
7. Andersen B.M., Rasch M., Hochlin K., Jensen F.H., Wismar P., Fredriksen J.E. Decontamination of rooms, medical equipment and ambulances using an aerosol of hydrogen peroxide disinfectant. J Hosp Infect 2006, 62:149-155.
8. Otter J.A., French G.L. Survival of nosocomial bacteria and spores on surfaces and inactivation by hydrogen peroxide vapor. J Clin Microbiol 2009, 47:205-207.
9. Boyce J.M., Havill N.L., Otter J.A., et al. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol 2008, 29:723-729.
10. Manian FA, Griesenauer S, Senkel D. Impact of an intensive terminal cleaning and disinfection (C/D) protocol involving selected hospital rooms on endemic nosocomial infection (NI) rates of common pathogens at a tertiary care medical center. In: Program and Abstracts of the 5th Decennial Meeting of the Society for Healthcare Epidemiology of America (SHEA). Arlington, VA: SHEA 2010. Abstract LB6.